Volterra Technologies’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49.1K Buy
+199
New +$50.6K 0.01% 302
2025
Q3
– Sell
-490
Closed -$160K – 343
2025
Q2
$160K Buy
+490
New +$136K 0.02% 366

Other funds holding ALNY

Volterra Technologies's ALNY Position: Q3 2026 in Review

Volterra Technologies opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 199 shares worth $49.1K. The stake represents 0.01% of the portfolio and ranks #302 among its holdings. This is a return to the name: Volterra Technologies previously reported a position in ALNY as recently as Q2 2025.

Volterra Technologies first reported a position in ALNY in Q2 2025 and has held it in 2 quarters since. The position peaked at $160K in Q2 2025. 722 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Volterra Technologies held 199 shares of Alnylam Pharmaceuticals worth $49.1K as of Q3 2026.
  • Alnylam Pharmaceuticals was a new Volterra Technologies position in Q3 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Volterra Technologies's portfolio in Q3 2026, its #302 holding.
  • Volterra Technologies first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • Volterra Technologies's Alnylam Pharmaceuticals position peaked at $160K in Q2 2025.
  • 722 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Volterra Technologies's 13F filing for Q3 2026, filed 16 Nov 2026.